Posted by SLS on January 30, 2013, at 23:14:18
In reply to Re: Nationwide ketamine trial for depression » Bob, posted by rovers95 on January 30, 2013, at 18:17:12
Another rapid-acting NMDA drug:
Naurex GLYX-13, like ketamine, interacts with the NMDA glutamate receptor. Unlike ketamine, it acts as a partial agonist of the glycine binding site rather than completely blocking the ion channel.
http://www.naurex.com/html/glyx13.html
http://www.clinicaltrials.gov/ct2/show/NCT01684163?term=Naurex+Depression+Study&rank=1
GLYX-13 is supposedly without psychotomimetic effects and has a wide therapeutic index.
Wichita, Kansas
Contact: Matthew Macaluso, MD 316-293-1833Princeton, New Jersey
Contact: Jeffery T. Apter, MD 609-921-3555Other sites can probably be found by contacting Naurex.
Contact: Lee Bastin, R.N. Ed.D. 847-871-0377 x119 leebastin@naurex.com
Contact: Ronald M Burch, MD PhD 203-247-3895 ronburch@naurex.com
- ScottSome see things as they are and ask why.
I dream of things that never were and ask why not.- George Bernard Shaw
poster:SLS
thread:1036666
URL: http://www.dr-bob.org/babble/20130124/msgs/1036931.html